[1] 蔡国响,戴卫星,蔡三军.结直肠癌多学科综合治疗的现状与未来[J].中华胃肠外科杂志,2016,19(6):607-611. [2] Doulabi H, Rastin M, Shabahangh H, et al.Analysis of Th22, Th17 and CD4+cells co-producing IL-17/IL-22 at different stages of human colon cancer[J]. Biomed Pharmacother, 2018, 103: 1101-1106. [3] Chow CJ, Al-Refaie WB, Abraham A, et al.Does patient rurality predict quality colon cancer care A population-based study[J]. Dis Colon Rectum, 2015, 58(4): 415-422. [4] 宋文,彭曼,段世玉,等. MIER3在结直肠癌中的表达及其相关蛋白的生物信息学分析[J]. 南方医科大学学报,2017,37(8):1040-1046. [5] West NR, Hegazy AN, Bmj O, et al.Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease[J]. Nature Medicine, 2017, 23(5): 579. [6] Dominguez C, David JM, Palena C.Epithelial-mesenchymal transition and inflammation at the site of the primary tumor[J]. Semin Cancer Biol, 2017, 47: 177-184. [7] Li S, Tian J, Zhang H, et al.Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer[J]. Apoptosis, 2018, 23(1): 1-19. [8] Guo Y, Wu R, Gaspar JM, et al.DNA Methylome and Transcriptome Alterations and Cancer Prevention by Curcumin in Colitis-accelerated Colon Cancer in Mice[J]. Carcinogenesis, 2018, 39(5): 669-680. [9] Grivennikov S, Karin E, Terzic J, et al.IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and? Development of Colitis-Associated Cancer[J]. Cancer Cell, 2009, 15(2): 91-102. [10] Cheng CC, Liao PN, Ho AS, et al.STAT3 exacerbates survival of cancer stem-like tumorspheres in EGFR-positive colorectal cancers: RNAseq analysis and therapeutic screening[J]. J Biomed Sci, 2018, 25(1): 60. [11] Zhao M, Tan Y, Peng Q, et al.IL-6/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation[J]. Nature Communications, 2018, 9(1): 583. [12] 王晓燕,梁磊,邓虹珠,等.苦参碱体外诱导人结肠腺癌SW620细胞凋亡的实验研究[J].南方医科大学学报,2008,28(3):432-435. [13] 张伟. 苦参碱对慢性心力衰竭大鼠心室重构的干预作用及其分子机制研究[D].宁夏医科大学,2011. |